Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
NCCN Annual Conference
NCCN Panel Debates Cancer Care in Value-Based Healthcare Models
By
Wayne Kuznar
NCCN Annual Conference
,
Value in Oncology
Web Exclusives
Experts at this roundtable discussion addressed high patient costs, achieving greater value in oncology care, and the desire for access to comparative data.
Read Article
NCCN Updates Its Clinical Practice Guidelines
By
Audrey Andrews
NCCN Annual Conference
May 2013, Vol 4, No 4
Updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines® were presented at the 2013 NCCN annual conference. The updates were minor for most tumor sites, but new guidelines were introduced for penile cancer and for survivorship.
Read Article
The Changing Oncology Landscape: Evolution or Revolution?
By
Audrey Andrews
NCCN Annual Conference
May 2013, Vol 4, No 4
Hollywood, FL—Panelists at the 2013 National Comprehensive Cancer Network (NCCN) annual conference view the oncology world as rapidly changing, and the impact of this, for better or for worse, will be felt by healthcare providers, payers, and patients alike.
Read Article
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma